Michelle A Peluso
CIK 1271739 · View on SEC EDGAR ↗
Insider
First SEC filing: Sept. 11, 2025 · Latest: Sept. 11, 2025
On this page
Insider at
Insider transactions
0 buys (P)
0 sells (S)
Net:
$0
+ 20 non-open-market transactions below
last 12 months, based on the transactions shown below
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Sept. 9, 2025 | NKE | A | 2,619 | — | — | 32,814 Direct | +8.67% | Acquired | (price as of 2026-08-21) |
| Sept. 10, 2024 | NKE | A | 2,437 | — | — | 30,195 Direct | +8.78% | Acquired | (price as of 2026-08-21) |
| Sept. 12, 2023 | NKE | A | 1,981 | — | — | 27,758 Direct | +7.69% | Acquired | (price as of 2026-08-21) |
| April 1, 2023 | CVS | A | 89,073 | $74.31 | $6,619,015 | 89,073 Direct | — | Acquired | 25.9% (price as of 2026-08-21) |
| April 1, 2023 | CVS | F | 98,299 | $74.31 | $7,304,599 | 124,383 Direct | -44.14% | Disposed | 25.9% (price as of 2026-08-21) |
| Feb. 27, 2023 | CVS | F | 12,304 | $85.77 | $1,055,314 | 222,682 Direct | -5.24% | Disposed | 9.1% (price as of 2026-08-21) |
| Feb. 2, 2023 | CVS | A | 192,554 | — | — | 207,465 Direct | +1291.36% | Acquired | (price as of 2026-08-21) |
| Sept. 9, 2022 | NKE | A | 1,804 | — | — | 25,777 Direct | +7.53% | Acquired | (price as of 2026-08-21) |
| April 1, 2022 | CVS | A | 57,172 | $101.09 | $5,779,517 | 57,172 Direct | — | Acquired | -7.4% (price as of 2026-08-21) |
| Feb. 26, 2022 | CVS | F | 12,609 | $104.30 | $1,315,119 | 14,911 Direct | -45.82% | Disposed | -10.3% (price as of 2026-08-21) |
| Oct. 6, 2021 | NKE | A | 1,206 | — | — | 23,973 Direct | +5.30% | Acquired | (price as of 2026-08-21) |
| Sept. 17, 2020 | NKE | A | 1,624 | — | — | 22,767 Direct | +7.68% | Acquired | (price as of 2026-08-21) |
| Sept. 19, 2019 | NKE | A | 1,996 | — | — | 21,143 Direct | +10.42% | Acquired | (price as of 2026-08-21) |
| Sept. 20, 2018 | NKE | A | 2,050 | — | — | 19,149 Direct | +11.99% | Acquired | (price as of 2026-08-21) |
| Sept. 21, 2017 | NKE | A | 3,103 | — | — | 17,099 Direct | +22.17% | Acquired | (price as of 2026-08-21) |
| Sept. 22, 2016 | NKE | A | 2,978 | — | — | 13,996 Direct | +27.03% | Acquired | (price as of 2026-08-21) |
| Sept. 17, 2015 | NKE | A | 1,389 | — | — | 5,509 Direct | +33.71% | Acquired | (price as of 2026-08-21) |
| July 6, 2015 | NKE | A | 6 | — | — | 4,120 Direct | +0.15% | Acquired | (price as of 2026-08-21) |
| Sept. 18, 2014 | NKE | A | 1,952 | — | — | 4,114 Direct | +90.29% | Acquired | (price as of 2026-08-21) |
| April 17, 2014 | NKE | A | 2,162 | — | — | 2,162 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| April 1, 2023 | CVS | Stock Option [F4] | Common Stock (89,073) | $74.31 | April 1, 2033 | 89,073 | Acquired |
| April 1, 2022 | CVS | Stock Option | Common Stock (57,172) | $101.09 | April 1, 2032 | 57,172 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 2 holdings
Securities held when first becoming an insider, per SEC Form 3.